This invention belongs to the fields of
genetic engineering and
fermentation engineering, and discloses a method for constructing and applying a
Schizochytrium strain that produces high DHA content. The engineered
Schizochytrium strain uses
Schizochytrium sp. HX308 as the starting strain. Through
metabolic engineering, a complete elongation-desaturation pathway is established in Schizochytrium (overexpression of C16 / 18
elongase, Δ-9
elongase gene, Δ-5 desaturase
gene, Δ-17 desaturase
gene, Δ-5
elongase gene, and Δ-4 desaturase gene), which works synergistically with the PKS pathway to produce DHA. The
peroxisome synthesis factor PEX10 is knocked out to obtain the recombinant engineered strain SCD3. In fed-
batch fermentation, the final DHA content of the engineered Schizochytrium strain SCD3 is the highest to date, reaching 70.1% of the total
fatty acid content. The oil and DHA yields are also significantly increased, reaching 67.9 g / L and 47.6 g / L, respectively. The DHA yield is 1.7 times that of the
wild type. This engineered strain has good application prospects.